
Name
GCP
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for GCP
Name
Alternate Names
Gemcitabine Hydrochloride
Gemzar
LY 188011
LY-188011
LY188011 hydrochloride
Gemcitabine HCL
Abbreviations
None
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
613327
Primary Site
Histology
None
Remarks
FDA approved for breast. ovarian, pancreas, NSC lung
Gemcitabine HCL is given intravesically as treatment for bladder tumors. Code as chemotherapy.
Gemcitabine HCL is given intravesically as treatment for bladder tumors. Code as chemotherapy.
Coding
This drug should be coded
Name
Alternate Names
BMS-181339-01
BMY-45622
Taxol
Abbreviations
None
Category
Chemotherapy
Subcategory
Mitotic inhibitor
plant alkaloid
Taxane
NSC Number
125973
673089
Primary Site
Histology
None
Remarks
Phase I (gastric) FDA approved uses on breast, ovarian, non-small cell lung cancers, and Kaposi's sarcoma. Bristol-Myers Squibb.
Coding
This drug should be coded
Name
Alternate Names
JM 8
JM-8
JM8
Paraplatin
Abbreviations
CBDCA
Category
Chemotherapy
Subcategory
Alkylating agent
Platinum analog
NSC Number
241240
Primary Site
All cancers
Histology
None
Remarks
A platinum-salt alkylating agent.
Coding
This drug should be coded
